CANCER THERAPY
ANGIOGENESIS AND CANCER THERAPY
... These inhibitors target VEGF receptors (VEGFR-1, VEGFR-2 and VEGFR-3). Also two mammalian target of rapamycin (mTOR) inhibitors; temsirolimus (Torisel) and everolimus (Afinitor) have been approved currently for ...
7
GOLD NANOPARTICLES IN CANCER THERAPY
... Gold nanoparticles have many properties that are attractive for the use in the cancer therapy. They are small and widely penetrate into the body, preferentially accumulating at the tumor sites owing to EPR ...
5
VEGF INHIBITORS FOR CANCER THERAPY
... have a direct and rapid anti-vascular effect in both animal and human tumors, through deprivation of tumor vascular supply and inhibition of endothelial proliferation. Several new tyrosine kinase inhibitors targeting the ...
11
STAT inhibitors for cancer therapy
... JAK/STAT pathways are major signaling channels for transmitting extracellular signals into the nuclei of cells. Monoclonal antibodies have been developed to target the signaling molecules along the related pathways ...
11
Epigenetics in cancer therapy and nanomedicine
... for cancer therapy (Fig. 5b). Many cancer cells, including tumor-initiating stem cells, are known to overexpress the HA-binding receptor CD44, and HA has often been modified with a drug carrier in ...
18
Kinetic model for designing a cancer therapy
... for cancer growth. Further, two different cancer therapies- EGFR inhibitor therapy and adoptive therapy- were ana- lyzed using this kinetic ...the cancer treatment therapies, and also ...
6
Nanotechnology of Cancer Therapy: An Overview
... effective cancer therapies capable of overcoming many biological, biophysical and biomedical barriers that the body stages against a standard ...to cancer cells are under ...drugdelivery, therapy, ...
7
Cancer Therapy Using Antibiotics
... Cancer therapy is as debilitating as the disease and though the global market for cancer drugs has hit billion dol- lars in annual sales the major limitation still remains with the toxicities that ...
10
Recombinant Viruses for Cancer Therapy
... for cancer therapy based on recombinant viruses, problems that need to be overcome, and possible prospects for further development of recombinant virus based ...
14
Targeting Mnks for Cancer Therapy
... targeted cancer therapy represents the remarkable progress of the decades’ research into mechanisms of cancer ...Most cancer drugs developed to date have been directed toward specific ...
14
Research Paper Nanoparticles in cancer therapy
... Targeted cancer therapy is a growing research area in cancer nanotechnology. Targeting strategies for nanoscale drug delivery illuminate possible mechanisms for nanoparticle-cancer tumour ...
10
Auger electrons for cancer therapy – a review
... for cancer therapy is that their cytotoxicity is restricted mostly to cells that bind and internalise the targeting ...irradiated cancer cells may still exert cytotoxic effects on non-targeted ...
36
Nanotechnology in Cancer Therapy
... effective cancer therapies capable of overcoming many biological, biophysical and biomedical barriers that the body stages against a standard ...to cancer cells are under ...drugdelivery, therapy, ...
8
targeted cancer therapy
... Targeted cancer therapy is a type of treatment that uses drugs to attack cancer cells, including some kinds of lung ...cause cancer, they have been able to develop drugs that directly target ...
44
Synthetic Biology for Breast Cancer Therapy
... breast cancer patients ...breast cancer cells has suggested the use of bispecific anti-HER-2/HER-3 antibody (TAb6) together with lapatinib in breast cancer therapy ...
6
CHOLESTEROL, BIOMARKERS AND CANCER THERAPY
... current cancer chemotherapy. The therapy focuses mainly on minimizing cytotoxicity and therapautic potential of these drugs is dependent on cellular ...etoposide therapy at 1mg/kg bodywt ip daily for ...
9
Nanotechnology in Cancer Therapy: A Review
... Also delivery of short interfering RNAs (siRNA) is interesting because siRNA simply stops the cancer tumor from growing and there is the potential to tailor synthetic siRNA to the version of cancer in an ...
8
Targeting mTOR for cancer therapy
... human cancer, such as L1460P, C1483F, E1799K, F1888L, T1977R, V2006I, V2046A, S2215Y, L2230V, E2388Q, I2500F, R2505P, and D2512H [127, ...161]. Cancer cells that harbor a subset of those mutations, ...
19
NANOTECHNOLOGY IN CANCER THERAPY
... nanotubes as high-resolution atomic force microscopy (AFM) tips, Woolley et al. Showed that specific sequences of kilo base-size DNA can be selectively detected from single-base mismatch sequences. Specifically, target ...
6
Cancer Therapy: Clinical
... We postulate that the long-term efficacy of the Ad.HSV.tk/ ganciclovir protocol was due to induction of a potent anti- tumor immune response. First, our biopsy studies showed that the intrapleural instillation of the ...
10